NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 312 filers reported holding NOVAVAX INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,440,218 | -52.1% | 140,099 | -15.1% | 0.00% | -66.7% |
| Q3 2022 | $3,004,000 | -57.8% | 165,046 | +19.2% | 0.00% | -57.1% |
| Q2 2022 | $7,120,000 | -36.8% | 138,435 | -9.5% | 0.01% | -22.2% |
| Q1 2022 | $11,268,000 | -52.4% | 152,998 | -7.5% | 0.01% | -43.8% |
| Q4 2021 | $23,663,000 | -30.9% | 165,393 | +0.1% | 0.02% | -38.5% |
| Q3 2021 | $34,264,000 | -0.4% | 165,281 | +2.0% | 0.03% | 0.0% |
| Q2 2021 | $34,400,000 | +28.6% | 162,026 | +9.8% | 0.03% | +30.0% |
| Q1 2021 | $26,760,000 | +76.4% | 147,595 | +8.5% | 0.02% | +66.7% |
| Q4 2020 | $15,174,000 | -0.4% | 136,081 | -3.2% | 0.01% | -14.3% |
| Q3 2020 | $15,237,000 | +40.7% | 140,624 | +8.2% | 0.01% | +27.3% |
| Q2 2020 | $10,833,000 | +3475.2% | 129,975 | +482.4% | 0.01% | – |
| Q1 2020 | $303,000 | +240.4% | 22,318 | 0.0% | 0.00% | – |
| Q4 2019 | $89,000 | -20.5% | 22,318 | 0.0% | 0.00% | – |
| Q3 2019 | $112,000 | -14.5% | 22,318 | 0.0% | 0.00% | – |
| Q2 2019 | $131,000 | – | 22,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |